skip-to-main

Spikevax (previously COVID‑19 Vaccine Moderna)

A Conditional Marketing Authorisation (CMA) has been granted in the EU for the product Spikevax (previously COVID‑19 Vaccine Moderna) to prevent coronavirus disease 2019 (COVID‑19) in people from 6 years of age.

Patient Information Leaflet

Patient Information Leaflet

Summary of Product Characteristics

Summary of Product Characteristics

Storage, Handling, Dosage and Administration

Storage, Handling, Dosage and Administration

Temperature Excursion Tool

Temperature Excursion Tool

See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.

Contact Moderna

8am-5pm CET – Mon - Fri
EMEAMedinfo@modernatx.com